Since SREBP-1c has been implicated to play a role in HCC, a longer treatment of kisspeptin will reveal whether kisspeptin/KISS1R signaling can downregulate SREBP-1c levels in advanced disease and HCC. Here, KISS1R is linked to hepatocellular carcinoma.